Skip to content
Medxy AI Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
  • Home
  • Specialties
  • Page 59
Global Health Landscape 1990-2023: Insights from the Global Burden of Disease Study 2023
Posted inPublic Health Specialties

Global Health Landscape 1990-2023: Insights from the Global Burden of Disease Study 2023

Posted by MedXY By MedXY 10/19/2025
This systematic analysis of the GBD 2023 presents global trends in disease burden, risk factors, and healthy life expectancy across 204 countries, elucidating shifts in NCDs, CMNN diseases, injuries, and underlying risk drivers crucial for guiding future health policy.
Read More
Comparative Risks of MASLD and MetALD: Insights from a Comprehensive Meta-Analysis on Hepatic and Extrahepatic Outcomes
Posted inGastroenterology Internal Medicine Specialties

Comparative Risks of MASLD and MetALD: Insights from a Comprehensive Meta-Analysis on Hepatic and Extrahepatic Outcomes

Posted by MedXY By MedXY 10/19/2025
This meta-analysis reveals that MetALD confers higher risks of liver-related events, hepatocellular carcinoma, and extrahepatic cancers compared to MASLD, while mortality and cardiovascular risks are similar, emphasizing tailored clinical approaches.
Read More
Bridging the Gaps in Global Diabetes Care: Insights from Two Decades of the Global Burden of Disease Study
Posted inDiabetes & Endocrinology news Public Health Specialties

Bridging the Gaps in Global Diabetes Care: Insights from Two Decades of the Global Burden of Disease Study

Posted by MedXY By MedXY 10/19/2025
A comprehensive analysis reveals ongoing challenges in diabetes diagnosis, treatment, and glycaemic control worldwide, highlighting the urgent need for enhanced care strategies, especially in low- and middle-income regions.
Read More
Enhanced Weight Reduction with Once-Weekly Semaglutide 7.2 mg in Obesity Management: Insights from the STEP UP Phase 3b Trial
Posted inDiabetes & Endocrinology Specialties

Enhanced Weight Reduction with Once-Weekly Semaglutide 7.2 mg in Obesity Management: Insights from the STEP UP Phase 3b Trial

Posted by MedXY By MedXY 10/18/2025
The STEP UP trial demonstrates that once-weekly semaglutide 7.2 mg significantly improves weight loss outcomes versus 2.4 mg and placebo in adults with obesity, with a manageable safety profile.
Read More
Emerging Threat: Active West Nile Virus Transmission in Brazil Reveals Critical Public Health Challenge
Posted inInfectious Diseases Neurology news

Emerging Threat: Active West Nile Virus Transmission in Brazil Reveals Critical Public Health Challenge

Posted by MedXY By MedXY 10/18/2025
Recent evidence confirms active West Nile virus transmission across Brazil with significant neurological impact and fatalities, emphasizing the need for enhanced surveillance and public health action in South America.
Read More
Ki-67 Dynamics During Neoadjuvant Chemotherapy: A Key to Better Breast Cancer Prognosis
Posted inHematology-Oncology OB/GYN & Women's Health Specialties

Ki-67 Dynamics During Neoadjuvant Chemotherapy: A Key to Better Breast Cancer Prognosis

Posted by MedXY By MedXY 10/18/2025
This study highlights the prognostic significance of tumor Ki-67 changes during neoadjuvant treatment, offering potential for improved risk stratification and personalized therapy in breast cancer patients.
Read More
Real-World Insights into HER2-Positive Metastatic Breast Cancer Treatments: Comparing T-DXd, T-DM1, and Tucatinib
Posted inInternal Medicine Oncology Specialties

Real-World Insights into HER2-Positive Metastatic Breast Cancer Treatments: Comparing T-DXd, T-DM1, and Tucatinib

Posted by MedXY By MedXY 10/18/2025
This study uses real-world data to compare the effectiveness and safety of trastuzumab deruxtecan versus trastuzumab emtansine and tucatinib in HER2-positive metastatic breast cancer, confirming their clinical value.
Read More
Early Adolescent Mental Well-Being as a Predictor of Long-Term Health Outcomes
Posted inPsychiatry Public Health Specialties

Early Adolescent Mental Well-Being as a Predictor of Long-Term Health Outcomes

Posted by MedXY By MedXY 10/18/2025
This study highlights how poor mental well-being during adolescence predicts increased risks of mental illness, risky behaviors, and mortality in young adulthood, emphasizing the urgency for early identification and intervention.
Read More
Evaluating the Necessity of Live Microbes in Fecal Microbiota Transplantation for C. difficile Recurrence: Insights from a Non-Inferiority Trial
Posted inGastroenterology Infectious Diseases news

Evaluating the Necessity of Live Microbes in Fecal Microbiota Transplantation for C. difficile Recurrence: Insights from a Non-Inferiority Trial

Posted by MedXY By MedXY 10/18/2025
This study investigates whether sterile lyophilised fecal filtrate is as effective as traditional donor stool in preventing recurrent C. difficile infection, highlighting the importance of live microbes in treatment efficacy.
Read More
Long-Term Sequelae in Survivors of High-Risk Neuroblastoma: Insights from the Children’s Oncology Group Study
Posted inOncology Pediatrics Specialties

Long-Term Sequelae in Survivors of High-Risk Neuroblastoma: Insights from the Children’s Oncology Group Study

Posted by MedXY By MedXY 10/18/2025
This study reveals significant late effects in childhood neuroblastoma survivors, emphasizing the need for targeted long-term follow-up care based on treatment exposures.
Read More
Evaluating the Impact of a Perioperative Care Bundle on Surgical Site Infection Prevention After Abdominal Surgery: Insights from the EPO2CH Trial
Posted inGeneral Surgery Infectious Diseases Specialties

Evaluating the Impact of a Perioperative Care Bundle on Surgical Site Infection Prevention After Abdominal Surgery: Insights from the EPO2CH Trial

Posted by MedXY By MedXY 10/18/2025
This comprehensive review explores the EPO2CH trial, which assessed a multi-component care bundle's effectiveness in reducing surgical site infections after abdominal surgery, highlighting key findings, limitations, and clinical implications.
Read More
Monlunabant Shows Promise for Weight Loss in Obesity and Metabolic Syndrome: A Phase 2A Trial Review
Posted inDiabetes & Endocrinology Internal Medicine Specialties

Monlunabant Shows Promise for Weight Loss in Obesity and Metabolic Syndrome: A Phase 2A Trial Review

Posted by MedXY By MedXY 10/18/2025
This phase 2a trial demonstrates that monlunabant induces significant weight loss across various doses in obese adults with metabolic syndrome, with dose-dependent adverse events highlighting the need for further safety evaluation.
Read More
Comparative Effectiveness of Long-Acting Injectable Versus Oral Antipsychotics in Older Adults with Schizophrenia: Insights from Hong Kong’s Population-Based Study
Posted inInternal Medicine Psychiatry Specialties

Comparative Effectiveness of Long-Acting Injectable Versus Oral Antipsychotics in Older Adults with Schizophrenia: Insights from Hong Kong’s Population-Based Study

Posted by MedXY By MedXY 10/18/2025
This study compares long-acting injectable to oral antipsychotics in older schizophrenia patients, highlighting benefits in relapse prevention and mortality reduction, with specific considerations for adverse effects.
Read More
Restrictive Treatment Criteria Improve Prognosis Prediction in Chronic Lymphocytic Leukemia: Insights from the Brazilian Registry
Posted inHematology-Oncology Specialties

Restrictive Treatment Criteria Improve Prognosis Prediction in Chronic Lymphocytic Leukemia: Insights from the Brazilian Registry

Posted by MedXY By MedXY 10/18/2025
A restrictive treatment initiation approach in CLL, endorsed by the Brazilian Group of CLL, identifies patients with higher risk more accurately and spares low-risk patients from unnecessary therapy, showing superior prognostic stratification compared to international guidelines.
Read More
Evaluating the Effectiveness of Circle of Security-Parenting for Perinatal Mental Health: Insights from a Large-Scale RCT
Posted inOB/GYN & Women's Health Psychiatry Specialties

Evaluating the Effectiveness of Circle of Security-Parenting for Perinatal Mental Health: Insights from a Large-Scale RCT

Posted by MedXY By MedXY 10/18/2025
This study finds no significant benefit of the Circle of Security-Parenting intervention added to usual care for improving mental health and bonding among new parents in NHS settings.
Read More
Rising Trends in Non-Lethal Self-Harm and Suicide in Spain (2018-2023): A Nationwide Registry Analysis with a Focus on Age and Gender
Posted inPsychiatry Public Health Specialties

Rising Trends in Non-Lethal Self-Harm and Suicide in Spain (2018-2023): A Nationwide Registry Analysis with a Focus on Age and Gender

Posted by MedXY By MedXY 10/18/2025
A nationwide study in Spain from 2018 to 2023 reveals increasing rates of non-lethal intentional self-harm and suicide, particularly among young women, underscoring the need for targeted mental health interventions.
Read More
Assessing the Nationwide Prevalence and Outcomes of Breast Cancer Patients Eligible for Adjuvant CDK4/6 Inhibitors
Posted inOB/GYN & Women's Health Oncology Specialties

Assessing the Nationwide Prevalence and Outcomes of Breast Cancer Patients Eligible for Adjuvant CDK4/6 Inhibitors

Posted by MedXY By MedXY 10/18/2025
This study offers insights into the prevalence, characteristics, and long-term survival of breast cancer patients eligible for adjuvant CDK4/6 inhibitors, highlighting real-world outcomes compared to clinical trial populations.
Read More
Hyperemesis Gravidarum and Depression: Unveiling the Bidirectional Link
Posted inOB/GYN & Women's Health Psychiatry Specialties

Hyperemesis Gravidarum and Depression: Unveiling the Bidirectional Link

Posted by MedXY By MedXY 10/18/2025
This comprehensive review examines the recent Finnish study highlighting the complex relationship between hyperemesis gravidarum and depression, emphasizing clinical implications for integrated mental health screening during reproductive care.
Read More
Deciphering the Impact of Resistance Genes on Antibiotic Efficacy in E. coli: Insights from a Comprehensive Study
Posted inInfectious Diseases Internal Medicine news

Deciphering the Impact of Resistance Genes on Antibiotic Efficacy in E. coli: Insights from a Comprehensive Study

Posted by MedXY By MedXY 10/18/2025
This study quantifies how specific resistance genes influence minimum inhibitory concentrations in E. coli, enhancing prediction accuracy for antibiotic resistance.
Read More
Advancing First-Line Treatment in Metastatic NSCLC: The Promise of Retifanlimab Combined with Chemotherapy
Posted inOncology Respiratory

Advancing First-Line Treatment in Metastatic NSCLC: The Promise of Retifanlimab Combined with Chemotherapy

Posted by MedXY By MedXY 10/17/2025
This article reviews the phase 3 POD1UM-304 trial demonstrating that adding retifanlimab to platinum-based chemotherapy improves overall survival in first-line metastatic NSCLC, highlighting its potential as a new standard of care.
Read More

Posts pagination

Previous page 1 … 57 58 59 60 61 … 149 Next page
  • High HIV Positivity Among Tuberculosis Household Contacts Underscores Need for Integrated Screening Strategies
  • Slow Tapering with Psychological Support Matches Medication Continuation for Relapse Prevention in Remitted Depression
  • Adolescent Body Dissatisfaction as a Causal Driver of Adult Mental Health: New Insights from a UK Twin Study
  • AUC3 2025: Expert Consensus Roadmap for Renal Cell and Urinary Tract Cancer Care
  • Tofacitinib Reverses Muscle Loss in Rheumatoid Arthritis: Insights from the RAMUS Trial
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

aging Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer cardiovascular disease cardiovascular health cardiovascular risk chronic kidney disease clinical trial clinical trials critical care depression diabetes epidemiology exercise health heart failure Hypertension immunotherapy inflammation MASLD mental health metformin Mortality multiple myeloma nutrition obesity older adults Pediatrics Physical Activity Pregnancy prevention prostate cancer public health randomized clinical trial randomized controlled trial randomized trial screening SGLT2 inhibitors targeted therapy type 2 diabetes weight loss women's health

Your health, we care

Copyright 2025 — Medxy AI. All rights reserved.
Scroll to Top
Sign in